LEIDEN, NETHERLANDS--(MARKET WIRE)--Jun 8, 2006 -- Biotech company Pharming Group NV ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) provided today an update on the acquisition of DNage BV ("DNage"). On March 24, 2006, Pharming announced that it had reached an agreement in principle with DNage under which Pharming will acquire all shares of DNage.
